Evidence map›Paper›PMID 28790389›Full record

ArticleScientific reports2017

Polyphyllin I suppresses human osteosarcoma growth by inactivation of Wnt/β-catenin pathway in vitro and in vivo.

Junli Chang, Yimian Li, Xianyang Wang, Shaopu Hu, Hongshen Wang, Qi Shi, Yongjun Wang, Yanping Yang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Saponins ofMolecules (Basel, Switzerland) · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Junli ChangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Yimian LiLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xianyang WangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Shaopu HuLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Hongshen WangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Qi ShiLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Yongjun WangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. yjwang8888@126.com.
Yanping YangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China. yanpingyangks@163.com.
Shanghai University of Traditional Chinese Medicine · CNLonghua Hospital Shanghai University of Traditional Chinese Medicine · CNMinistry of Education of the People's Republic of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteosarcoma is the most common primary bone cancer in children and adolescents. In spite of aggressive treatment, osteosarcoma has a high mortality rate with minimal improvements in survival over past few decades. Polyphyllin I (PPI), a component in the traditional Chinese medicinal herb Paris polyphylla Smith, has been shown to have anti-tumor properties. However, its mechanism as an anti-osteosarcoma agent has not been well elucidated. In this study, we found that PPI suppressed osteosarcoma cell viability, arrested cell cycle in G

Indexed as

Gene Expression Regulation, NeoplasticAnimalsAntineoplastic Agents, PhytogenicApoptosisbeta CateninBone NeoplasmsCell Line, TumorCell MovementDiosgeninG2 Phase Cell Cycle CheckpointsGlycogen Synthase Kinase 3 betaHumansMaleMiceMice, NudeOsteosarcomaAntineoplastic Agents, Phytogenicbeta CateninChir 99021CTNNB1 protein, humanDiosgeninGlycogen Synthase Kinase 3 betapolyphyllin IProtein Kinase InhibitorsPyridinesPyrimidinesRNA, Small InterferingWnt Proteins

Identifiers

PMID28790389
PMCPMC5548759
OpenAlexW2739827817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.